Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 927 of 1,261

  1. US 8158773

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  2. US 8158658

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  3. US 8158677

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  4. US 8158621

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  5. US 8158659

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  6. US 8158126

    Stem cell fusion model of carcinogenesis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  7. US 8153781

    Dendrimer conjugates of agonists and antagonists of the GPCR superfamily

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  8. US 8153804

    Aryl pyridines and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  9. US 8153694

    Cyclopropanecarboxylic acid compound

    Takeda Pharmaceutical Company Limited · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  10. US 8153686

    Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  11. US 8153655

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  12. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  13. US 8153675

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  14. US 8153668

    Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  15. US 8153642

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  16. US 8153609

    Purine nucleotide derivatives

    Lauras AS · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  17. US 8153604

    CNS-tumor treatment method and composition

    The Regents of the University of California · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  18. US 8153426

    Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  19. US 8153156

    Hydrogel nanocompsites for ophthalmic applications

    The United States of America as represented by the Department of Veteran Affairs · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  20. US 8153136

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  21. US 8153103

    Conjugates of photo-activatable dyes

    The Board of Regents of the University of Texas System · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  22. US 8153690

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Esperion Therapeutics, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  23. US 8153116

    Use of conditional plasmodium strains lacking an essential gene in malaria vaccination

    UNIVERSITY OF CONNECTICUT · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  24. US 8153620

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.